TRiAD - Publications

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

18 May 2022

By Samantha Pillay

Rapid communication: Key changes to the treatment of drug-resistant tuberculosis

02 May 2022

By WHO

High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis

23 Mar 2022

By Andrew D. McCallum

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

08 Mar 2022

By Timothy M Walker

Can the GeneXpert MTB/XDR deliver on the promise of expanded, near-patient tuberculosis drug-susceptibility testing?

25 Feb 2022

By Kogie Naidoo,

Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis

21 Dec 2021

By Christiaan Mulder

Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin

07 Oct 2021

By Nomonde R Mvelase

Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study

07 Oct 2021

By Adam Penn-Nicholson

WHO consolidated guidelines on tuberculosis - Module 3: Rapid diagnostics for tuberculosis detection

21 Jul 2021

By WHO

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

16 Jul 2021

By Sarah van de Berg

Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection

10 Apr 2021

By Sophia B Georghiou

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts

05 Apr 2021

By Suzette Oelofse

Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum

22 Nov 2020

By Yuan Cao

Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay

30 Apr 2020

By Wilber Sabiiti

Introducing bedaquiline: experiences from the Challenge TB Project

26 Apr 2020

By Caitlyn G Edwards

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

05 Mar 2020

By ‪Francesca Conradie‬

Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture

23 Sep 2019

By Robin J. Svensson